Examples of using Impaired hepatic function in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Dose adjustment is not required in patients with mildly impaired hepatic function Child Pugh A.
Thus, decitabine exposure is not likely to be affected in patients with impaired hepatic function.
The mean AUC(0-∞) was 42% greater in subjects with impaired hepatic function than in healthy subjects.
Do not use in dogs with severely impaired hepatic function, severe renal
There is insufficient experience of the use of topotecan in patients with severely impaired hepatic function serum bilirubin 10 mg/dl.
Concentrations of atazanavir given with cobicistat are expected to be increased in patients with impaired hepatic function(see sections 4.2 and 4.4).
Dexrazoxane has not been studied in patients with impaired hepatic function and its use in such patients is not recommended(see section 4.4).
consideration should be given to reduced starting doses in patients with impaired hepatic function.
Patients with renal impairment associated with impaired hepatic function should inform the physician about the problem
Furosemide should be used with caution in case of pre-existing electrolyte and/or water imbalance, impaired hepatic function(may precipitate hepatic coma)
If you have kidney problems(severely impaired renal function) and/or liver problems(severely impaired hepatic function), other medicines containing any of the following active substances.
or severely impaired hepatic function serum bilirubin.
Intensified monitoring of adverse reactions is recommended in patients with impaired hepatic function as exposure is expected to be increased in this population, in particular in patients with severe hepatic impairment.
In addition, Actelsar HCT should be used with caution in patients with impaired hepatic function or progressive liver disease,
Although erlotinib exposure was similar in patients with moderately impaired hepatic function(Child- Pugh score 7-9) compared with patients with adequate hepatic function,
110 subjects with advanced malignancies and either normal or impaired hepatic function, concentrations of temsirolimus
The effect of impaired hepatic function on the pharmacokinetics of vildagliptin was studied in patients with mild,
However, post- hoc analysis of data from the two Phase 3 clinical trials showed that the pharmacokinetics of regadenoson were not affected in a small subset of patients with laboratory values suggestive of impaired hepatic function 2.5-fold transaminase elevation or 1.5-fold elevation of serum bilirubin or prothrombin time.